Bacterial Vaginosis
Trial provides ‘substantial evidence’ that bacterial vaginosis is sexually transmitted
The addition of treatment for male partners reduced the recurrence of bacterial vaginosis among women enrolled in a randomized trial compared with treating only the women, researchers reported.
Monthly hormone-free contraceptive device successfully blocks sperm in early-phase study
An investigational hormone-free contraceptive device left in place for 21 days demonstrated preliminary evidence of contraceptive efficacy in a small early-phase study, researchers reported in Contraception.
Top in women's health: Debunking 'morning sickness' myths; vaccines not linked to bleeding
Nausea and vomiting of pregnancy is a common condition, occurring in 50% to 80% of pregnancies, and it is associated with positive fetal outcomes and a reduced risk for pregnancy loss, research has shown.
Q&A: Normalize seeking proper bacterial vaginosis diagnosis, treatment
Bacterial vaginosis is a common infection many U.S. women experience, but there continue to be knowledge gaps requiring research to help understand its development, risk factors and treatment.
Bacterial vaginosis associated with higher rates of chlamydia persistence
Bacterial vaginosis is associated with higher rates of chlamydia persistence vs. spontaneous clearing, the Longitudinal Study of Vaginal Flora showed.
LACTIN-V reduces recurrent bacterial vaginosis risk following cure with antibiotics
Recurrent bacterial vaginosis (BV) impacts quality of life, but treatment is currently limited to repeated courses of antibiotics.
FDA approves gel for bacterial vaginosis
Daré Bioscience announced the FDA approval of Xaciato, a vaginal gel, for the treatment of bacterial vaginosis in females aged 12 years or older.
Secnidazole ‘highly effective’ for trichomoniasis in US women
A single oral dose of secnidazole increased microbiological cure rates among women with trichomoniasis who were enrolled in a randomized controlled trial in the United States, including women with HIV or bacterial vaginosis.
L. crispatus decreases bacterial vaginosis recurrence after treatment with metronidazole
Using Lactobacillus crispatus CTV-05, or Lactin-V, after treatment with vaginal metronidazole lowers of bacterial vaginosis recurrence in women, according to a study published in New England Journal of Medicine.
USPSTF: Avoid screening asymptomatic pregnant women for bacterial vaginosis
The U.S. Preventive Services Task Force recommended against screening for bacterial vaginosis in asymptomatic pregnant women who are not at increased risk for preterm delivery. The task force also said there is insufficient evidence to assess the balance of benefits and harms of screening for bacterial vaginosis in asymptomatic pregnant women who are at increased risk for preterm delivery.